Home About us Contact
|
Home About us Contact | ||
|
|
||
Cytopathology
Selected AbstractsWHO SHOULD BE REPORTING GYNAECOLOGICAL CYTOPATHOLOGY?CYTOPATHOLOGY, Issue 1 2000M. C. J. Sissons No abstract is available for this article. [source] EDITORIAL: Cytopathology of oral infectious diseases: do we really do our best?CYTOPATHOLOGY, Issue 5 2010G. Cathomas No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 4 2010Article first published online: 7 JUL 2010 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 2 2010Article first published online: 5 MAR 2010 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 1 2010Article first published online: 5 JAN 2010 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 5 2009Article first published online: 10 SEP 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 4 2009Article first published online: 16 JUL 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 3 2009Article first published online: 13 MAY 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 2 2009Article first published online: 19 MAR 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 1 2009Article first published online: 8 JAN 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 6 2008Article first published online: 19 NOV 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 5 2008Article first published online: 14 SEP 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 3 2008Article first published online: 19 MAY 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 2 2008Article first published online: 18 MAR 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 1 2008Article first published online: 15 JAN 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 6 2007Article first published online: 19 NOV 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 5 2007Article first published online: 20 SEP 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 4 2007Article first published online: 18 JUL 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 3 2007Article first published online: 15 JUN 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 1 2007Article first published online: 23 JAN 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 6 2006Article first published online: 27 NOV 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 5 2006Article first published online: 8 SEP 200 No abstract is available for this article. [source] THE MOLECULAR FUTURE IN CYTOLOGYCYTOPATHOLOGY, Issue 2006M. Salto-Tellez Molecular diagnosis is the application of molecular biology techniques and knowledge of the molecular mechanisms of disease to diagnosis, prognostication and treatment of diseases. Molecular Diagnosis is, arguably, the fastest growing area of diagnostic medicine. The US market for molecular testing generated $1.3 billion in 2000, which was predicted to increase to about $4.2 billion by 2007.1 We proposed the term Diagnostic Molecular Cytopathology to define the application of molecular diagnosis to cytopathology2. Diagnostic Molecular Cytopathology is essential for the following reasons: (i) Molecular testing is sometimes indispensable to establish an unequivocal diagnosis on cell preparations; (ii) Molecular testing provides extra information on the prognosis or therapy of diseases diagnosed by conventional cytology; (iii) Molecular testing provides genetic information on the inherited nature of diseases that can be directly investigated in cytology samples, by either exfoliation or by fine needle aspiration; (iv) Sometimes the cytopathology sample is the most convenient (or the only available) source of material for molecular testing; (v). Direct molecular interrogation of cells allows for a diagnostic correlation that would otherwise not be possible. Parallel to this direct diagnostic implication, cytopathology is increasing important in the validation of biomarkers for specific diseases, and in therefore of significant importance in the overall translational research strategies. We illustrate its application in some of the main areas of oncology molecular testing, such as molecular fingerprinting of neoplasms,3 lymphoreticular diseases,2 sarcomas4 and lung cancer,5 as well as translational research using diagnostic cytopathology techniques. The next years will see the consolidation of Diagnostic Molecular Cytopathology, a process that will lead to a change of many paradigms. In general, diagnostic pathology departments will have to reorganize molecular testing to pursue a cost-efficient operation. Sample preparation will have to take into account optimal preservation of nuclear acids. The training of technical staff and the level of laboratory quality control and quality assurance would have to follow strict clinical (not research) laboratory parameters. And, most importantly, those pathologists undertaking molecular diagnosis as a discipline would have to develop their professional expertise within the same framework of fellowships and professional credentials that is offered in other sub-specialties. The price to pay if this effort is not undertaken is too important for the future of diagnostic pathology in general. The increasing characterization of molecular biomarkers with diagnostic, prognostic or therapeutic value is making the analysis of tissue and cell samples prior to treatment a more complex exercise. If cytopathologists and histopathologists allow others to take charge of molecular diagnosis, our overall contribution to the diagnostic process will be diminished. We may not become less important, but we may become less relevant. However, those within the discipline of diagnostic pathology who can combine the clinical background of diseases with the morphological, immunocytochemical and molecular diagnostic interpretation will represent bona fide diagnostic specialists. Such ,molecular cytopathologists' would place themselves at the centre of clinical decision-making. Reference:, 1. Liz Fletcher. Roche leads molecular diagnostics charge. Nature Biotechnol 20, 6,7; 2002 2. Salto-Tellez M and Koay ESC. Molecular Diagnostic Cytopathology - Definitions, Scope and Clinical Utility. Cytopathology 2004; 15:252,255 3. Salto-Tellez M, Zhang D, Chiu LL, Wang SC, Nilsson B, and Koay ESC. Immunocytochemistry Versus Molecular Fingerprinting of Metastases. Cytopathology, 2003 Aug; 14(4):186,90. 4. Chiu LL, Koay SCE, Chan NL and Salto-Tellez M. Molecular Cytopathology: Sequencing of the EWS-WT1 Gene Fusion Transcript in the Peritoneal Effusion of a Patient with Desmoplastic Small Round Cell Tumour. Diagnostic Cytopathology, 2003 Dec; 29(6): 341,3. 5. TM Chin, D Anuar, R Soo, M Salto-Tellez, WQ Li, B Ahmad, SC Lee, BC Goh, K Kawakami, A Segal, B Iacopetta, R Soong. Sensitive and Cost-Effective deptection of epidermal growth factor Receptor Mutations in Small Biopsies by denaturing High Performance Liquid Chromatography. (In press). [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 4 2006Article first published online: 18 JUL 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 3 2006Article first published online: 23 MAY 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 2 2006Article first published online: 21 MAR 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 1 2006Article first published online: 16 JAN 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 6 2005Article first published online: 22 NOV 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 5 2005Article first published online: 22 SEP 200 No abstract is available for this article. [source] From this month's CytopathologyCYTOPATHOLOGY, Issue 4 2005Article first published online: 25 JUL 200 No abstract is available for this article. [source] | |||||||||||||